Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Eppendorf will be a Gold Sponsor of the BioLabs | TUM site, which opened this past summer.
October 21, 2026
By: Patrick Lavery
Editor’s Take: Extending this partnership to the Munich site continues a relationship that already spans Germany, France, and the U.S.
Eppendorf and BioLabs announced their pre-existing collaboration is extending to the new BioLabs | TUM site in Munich. The two companies’ relationship already includes BioLabs locations in Germany, as well as the United States and France.
This site, which opened in summer 2026, offers both shared and private laboratory spaces. Also contained there are offices and operational support, plus access to a roster of entrepreneurs, mentors, investors, and other partners.
Eppendorf, which develops, manufactures, and distributes laboratory instruments, consumables, and services worldwide, will be a BioLabs | TUM Gold Sponsor. BioLabs says Eppendorf will contribute technologies and expertise supporting day-to-day research and growth.
Axel Ziemke, Vice President Central Area EMEA, Eppendorf Vertrieb Deutschland GmbH, says this expansion serves a new generation of biotechs. This is particularly true in terms of accessibility to Eppendorf’s equipment and expertise, Ziemke says.
And, Ziemke also adds, the partnership’s practical lab support combines with opportunities for “direct exchange” between Eppendorf and innovative companies.
Meanwhile, BioLabs CEO and Founder Johannes Fruehauf reflected on the two companies’ relationship to date.
“BioLabs’ partnership with Eppendorf spans more than a decade,” Fruehauf said. “We are very proud to extend this long-standing collaboration to Munich. Our mission is to support entrepreneurs and innovative scientists as they bring breakthrough ideas to life. We are confident that Eppendorf shares that commitment. We are excited to have Eppendorf join us in supporting the next generation of life-science companies in Munich.”
Fruehauf adds that the two sides intend to further build upon their collaboration within the life sciences ecosystem in Munich.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !